Healthcare & Medical

Cancer Genomics Consortium (CGC) Annual Meeting 2026

Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. Sequence short to ultra-long DNA/RNA fragments, for a streamlined and rapid solution to comprehensively characterise cancer and tumour research samples: from SNVs to epigenetic alterations and large-scale structural ab…

Visit the official site
2Speakers
1Sponsors
1Exhibitors
0On the bill · sessions
2Companies · in total
§I

Speakers

Programmed at Cancer, in alphabetical order.
Cate Randall Paschal
PhD, FACMG, CGC 2026 Program Committee Chair · Cancer Genomics Consortium
Cate Randall Paschal, PhD, FACMG
Program Committee Chair · Cancer Genomics Consortium
§II

Sponsors

The houses behind the program. Tiers as disclosed.
Oxford Nanopore Technologies
Intermission
Part the Second · For the Buyer

What does it mean when 2 companies show up, and 1 bet on three roles at once?

Two companies. one are betting more than once.

The numbers below are derived from the speakers, sponsors, and exhibitors on this page, cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

Who's in the room
1All threespeak · spons · exh
0Sponsoringsponsor only
0Exhibitingexhibitor only
1Companies Speakingspeaker only

The Triple-Threat

Oxford Nanopore Technologies

Speakers by seniority
  • Other roles2100%

Of 2 on the bill · classified by free-text title

Most-represented companies
  1. 01Oxford Nanopore TechnologiesSpEx
  2. 02Cancer Genomics Consortium2V
Sponsors by tier
unspecified1
100% of 1